Chemical Bank cut its position in shares of Clorox Company (The) (NYSE:CLX) by 2.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,095 shares of the company’s stock after selling 190 shares during the quarter. Chemical Bank’s holdings in Clorox Company (The) were worth $1,212,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. boosted its position in shares of Clorox Company (The) by 2.4% during the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after purchasing an additional 25,110 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Clorox Company (The) by 4.3% during the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after purchasing an additional 51,563 shares in the last quarter. Destination Wealth Management boosted its position in shares of Clorox Company (The) by 14.0% during the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after purchasing an additional 3,716 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its position in shares of Clorox Company (The) by 4.0% during the first quarter. Nomura Asset Management Co. Ltd. now owns 71,366 shares of the company’s stock valued at $9,623,000 after purchasing an additional 2,714 shares in the last quarter. Finally, IMS Capital Management bought a new stake in shares of Clorox Company (The) during the second quarter valued at approximately $168,000. Institutional investors own 71.28% of the company’s stock.

In related news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares in the company, valued at $2,862,666.18. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 21,242 shares of company stock valued at $2,944,449. 0.74% of the stock is owned by insiders.

WARNING: This news story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/09/14/chemical-bank-reduces-position-in-clorox-company-the-clx.html.

Several research firms recently weighed in on CLX. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday. Jefferies Group LLC restated a “hold” rating and set a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC restated an “equal weight” rating and set a $136.00 price target (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Finally, BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $129.05.

Shares of Clorox Company (CLX) traded down 0.23% during trading on Thursday, hitting $133.77. The company had a trading volume of 99,933 shares. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The firm has a market capitalization of $17.27 billion, a P/E ratio of 25.07 and a beta of 0.40. The stock’s 50-day moving average is $135.79 and its 200 day moving average is $135.26.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.30 earnings per share. Equities research analysts predict that Clorox Company will post $5.66 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a yield of 2.51%. Clorox Company (The)’s payout ratio is currently 63.04%.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.